Sanofi announced that Audrey Duval Derveloy, a seasoned healthcare industry leader and Sanofi France?s President, has been named Executive Vice President, Global Head of Corporate Affairs. Audrey will become a member of Sanofi?s Executive Committee, reporting into CEO Paul Hudson, and will be based in Paris. Her appointment is effective July 1, 2024.

In her new role, Audrey will be responsible for Sanofi?s stakeholder engagement globally, and oversee the company?s corporate social responsibility strategy, not-for-profit Global Health Unit and Sanofi?s philanthropic arm, Foundation S. Audrey retains her role as President, Sanofi France, and will continue supporting and coordinating Sanofi?s representation to its various external stakeholders in this country. Audrey joined Sanofi from Novartis to serve as President, Sanofi France, in September 2022. A physician by training, she started her career in public hospitals in Paris.

She then worked as a Researcher at the Pasteur Research Center of Hong Kong University and later as a Scientific Expert at Salusmed, based in Hong Kong. She returned to France to join Pfizer, working in medical affairs in the areas of Endocrinology, Transplant and Rheumatology. Audrey later joined Novartis in France, where she progressively advanced to become Business Franchise Head for Ophthalmology and then, in 2020, Country President for the company?s operations in Ireland.

Audrey holds a Medical Doctorate from the Paris Faculté de Médécine Cochin, and a Bachelor of Science in Medical Biology.